Stay updated on ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial

Sign up to get notified when there's something new on the ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial page.
Screenshot error
Open in browserReport Problem
Clouds background image

Latest updates to the ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial page

  1. Check
    15 days ago
    Change Detected
    Summary
    The page has undergone a revision from v2.8.1 to v2.15.0, with significant changes in the presentation of intervention types and the information regarding publications from PubMed.
    Difference
    1.0%
    Check dated 2025-04-24T02:23:25.000Z thumbnail image
  2. Check
    329 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the webpage content.
    Difference
    0.1%
    Check dated 2024-06-14T01:56:26.000Z thumbnail image
  3. Check
    332 days ago
    Change Detected
    Summary
    The value representing the Percentage Change in LDL-C From Baseline of the ORION-1 Study (Inclisiran Arm) has recently changed to 2. This change indicates the updated percentage change in LDL-C levels from baseline to specific time points in the study.
    Difference
    5%
    Check dated 2024-06-10T21:35:12.000Z thumbnail image
  4. Check
    333 days ago
    Change Detected
    Summary
    The value 2. Percentage Change in LDL-C From Baseline of the ORION-1 Study (Inclisiran Arm) has recently changed. This change represents an update in the percentage change in LDL-C levels from baseline in the ORION-1 study to a specific time point in the ORION-3 study, providing insights into the efficacy of inclisiran treatment over time.
    Difference
    4%
    Check dated 2024-06-09T20:05:01.000Z thumbnail image
  5. Check
    336 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a shift in the percentage change in LDL-C from baseline of the ORION-1 study to Day 210 in ORION-3 for the Inclisiran arm, reflecting potential updates in the study results related to cardiovascular health and cholesterol management.
    Difference
    0.1%
    Check dated 2024-06-06T16:09:03.000Z thumbnail image
  6. Check
    351 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a change in the type of intervention for the study. The new information specifies that participants received subcutaneous injections of inclisiran and evolocumab at different intervals, with a detailed schedule for each drug administration.
    Difference
    91%
    Check dated 2024-05-22T14:44:22.000Z thumbnail image

Stay in the know with updates to ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial page.